Table 2.
The characteristics of patients with Kawasaki disease according to development of CADs
| CADs (-) N = 740 | CADs ( +) N = 156 | P value | |
|---|---|---|---|
| Age, months | 31.86 ± 22.54 | 32.92 ± 26.15 | 0.60 |
| Sex | 0.53 | ||
| Male, n (%) | 418 (56.4%) | 93 (59.6%) | |
| Female, n (%) | 322 (43.5%) | 63 (40.3%) | |
| WBC, 103/L | 14.73 ± 4.75 | 15.22 ± 5.10 | 0.25 |
| ANC, 103/L | 9.59 ± 4.44 | 10.71 ± 4.87 | < 0.01 |
| Hematocrit, % | 34.40 ± 13.06 | 34.33 ± 5.08 | 0.94 |
| Platelet, 103/L | 358.78 ± 101.58 | 346.15 ± 103.82 | 0.16 |
| AST, U/L | 83.23 ± 144.13 | 103.38 ± 169.70 | 0.12 |
| ALT, U/L | 81.05 ± 130.57 | 129.67 ± 169.03 | < 0.01* |
| Albumin, g/dL | 3.97 ± 0.95 | 3.82 ± 0.44 | 0.04 |
| Total bilirubin, mg/dL | 0.64 ± 0.82 | 1.04 ± 1.14 | < 0.01* |
| CRP, mg/dL | 7.94 ± 5.68 | 9.77 ± 6.85 | < 0.01* |
| Na, mmol/L | 136.37 ± 2.71 | 135.67 ± 3.01 | < 0.01* |
| NT-proBNP, pg/mL | 1192.48 ± 2049.08 | 2268.57 ± 4136.75 | < 0.01* |
| IVIG resistance, n (%) | 72 (9.7%) | 39 (25.0%) | < 0.01* |
mean ± standard deviation or number (%). *means statistically significant; p values < 0.05
IVIG Intravenous immunoglobulin, WBC White blood cells, ANC Absolute neutrophil counts, AST Aspartate aminotransferase, ALT Alanine transaminase, CRP C-reactive protein, NT-proBNP Nitrogen terminal- pro brain natriuretic peptide, CAD Coronary artery dilatation